Literature DB >> 25867068

Fer tyrosine kinase oligomer mediates and amplifies Src-induced tumor progression.

C Oneyama1, Y Yoshikawa1, Y Ninomiya1, T Iino1, S Tsukita2, M Okada1.   

Abstract

c-Src is upregulated in various human cancers, suggesting its role in malignant progression. However, the molecular circuits of c-Src oncogenic signaling remain elusive. Here we show that Fer tyrosine kinase oligomer mediates and amplifies Src-induced tumor progression. Previously, we showed that transformation of fibroblasts is promoted by the relocation of c-Src to non-raft membranes. In this study, we identified Fer and ezrin as non-raft c-Src targets. c-Src directly activated Fer by initiating its autophosphorylation, which was further amplified by Fer oligomerization. Fer interacted with active c-Src at focal adhesion membranes and activated Fer-phosphorylated ezrin to induce cell transformation. Fer was also crucial for cell transformation induced by v-Src or epidermal growth-factor receptor activation. Furthermore, Fer activation was required for tumorigenesis and invasiveness in some cancer cells in which c-Src is upregulated. We propose that the Src-Fer axis represents a new therapeutic target for treatment of a subset of human cancers.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25867068     DOI: 10.1038/onc.2015.110

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  47 in total

Review 1.  Closing in on the biological functions of Fps/Fes and Fer.

Authors:  Peter Greer
Journal:  Nat Rev Mol Cell Biol       Date:  2002-04       Impact factor: 94.444

2.  Detergent resistance as a tool in membrane research.

Authors:  Daniel Lingwood; Kai Simons
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

3.  Links between Fer tyrosine kinase expression levels and prostate cell proliferation.

Authors:  P Allard; A Zoubeidi; L T Nguyen; S Tessier; S Tanguay; M Chevrette; A Aprikian; S Chevalier
Journal:  Mol Cell Endocrinol       Date:  2000-01-25       Impact factor: 4.102

4.  Transmembrane phosphoprotein Cbp regulates the activities of Src-family tyrosine kinases.

Authors:  M Kawabuchi; Y Satomi; T Takao; Y Shimonishi; S Nada; K Nagai; A Tarakhovsky; M Okada
Journal:  Nature       Date:  2000-04-27       Impact factor: 49.962

Review 5.  Src in cancer: deregulation and consequences for cell behaviour.

Authors:  Margaret C Frame
Journal:  Biochim Biophys Acta       Date:  2002-06-21

6.  Activating SRC mutation in a subset of advanced human colon cancers.

Authors:  R B Irby; W Mao; D Coppola; J Kang; J M Loubeau; W Trudeau; R Karl; D J Fujita; R Jove; T J Yeatman
Journal:  Nat Genet       Date:  1999-02       Impact factor: 38.330

7.  Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators.

Authors:  Yanlin Yu; Javed Khan; Chand Khanna; Lee Helman; Paul S Meltzer; Glenn Merlino
Journal:  Nat Med       Date:  2004-01-04       Impact factor: 53.440

8.  Constitutive activation of Src family kinases in mouse embryos that lack Csk.

Authors:  S Nada; T Yagi; H Takeda; T Tokunaga; H Nakagawa; Y Ikawa; M Okada; S Aizawa
Journal:  Cell       Date:  1993-06-18       Impact factor: 41.582

9.  A SARCOMA OF THE FOWL TRANSMISSIBLE BY AN AGENT SEPARABLE FROM THE TUMOR CELLS.

Authors:  P Rous
Journal:  J Exp Med       Date:  1911-04-01       Impact factor: 14.307

10.  ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons.

Authors:  S Tsukita; K Oishi; N Sato; J Sagara; A Kawai; S Tsukita
Journal:  J Cell Biol       Date:  1994-07       Impact factor: 10.539

View more
  9 in total

1.  High-resolution structural analysis shows how different crystallographic environments can induce alternative modes of binding of a phosphotyrosine peptide to the SH2 domain of Fer tyrosine kinase.

Authors:  Yoshiyuki Matsuura
Journal:  Protein Sci       Date:  2019-08-31       Impact factor: 6.725

2.  FER-mediated phosphorylation and PIK3R2 recruitment on IRS4 promotes AKT activation and tumorigenesis in ovarian cancer cells.

Authors:  Yanchun Zhang; Xuexue Xiong; Qi Zhu; Jiali Zhang; Shengmiao Chen; Yuetong Wang; Jian Cao; Li Chen; Linjun Hou; Xi Zhao; Piliang Hao; Jian Chen; Min Zhuang; Dake Li; Gaofeng Fan
Journal:  Elife       Date:  2022-05-12       Impact factor: 8.713

3.  FES-related tyrosine kinase activates the insulin-like growth factor-1 receptor at sites of cell adhesion.

Authors:  Joanna Stanicka; Leonie Rieger; Sandra O'Shea; Orla Cox; Michael Coleman; Ciara O'Flanagan; Barbara Addario; Nuala McCabe; Richard Kennedy; Rosemary O'Connor
Journal:  Oncogene       Date:  2018-03-15       Impact factor: 9.867

Review 4.  Sponges: A Reservoir of Genes Implicated in Human Cancer.

Authors:  Helena Ćetković; Mirna Halasz; Maja Herak Bosnar
Journal:  Mar Drugs       Date:  2018-01-10       Impact factor: 5.118

5.  Sensitive and rapid quantification of exosomes by fusing luciferase to exosome marker proteins.

Authors:  Tomoya Hikita; Mamiko Miyata; Risayo Watanabe; Chitose Oneyama
Journal:  Sci Rep       Date:  2018-09-19       Impact factor: 4.379

6.  Discovery of Long Non-Coding RNA MALAT1 Amplification in Precancerous Colorectal Lesions.

Authors:  Anna Siskova; Jan Kral; Jana Drabova; Klara Cervena; Kristyna Tomasova; Jiri Jungwirth; Tomas Hucl; Pavel Kohout; Sandra Summerova; Ludmila Vodickova; Pavel Vodicka; Veronika Vymetalkova
Journal:  Int J Mol Sci       Date:  2022-07-11       Impact factor: 6.208

7.  FER Regulated by miR-206 Promotes Hepatocellular Carcinoma Progression via NF-κB Signaling.

Authors:  Wenzhou Ding; Ye Fan; Wenbo Jia; Xiongxiong Pan; Guoyong Han; Yao Zhang; Zhiqiang Chen; Yiwei Lu; Jinyi Wang; Jindao Wu; Xuehao Wang
Journal:  Front Oncol       Date:  2021-07-05       Impact factor: 6.244

8.  Regulation of E3 ubiquitin ligase-1 (WWP1) by microRNA-452 inhibits cancer cell migration and invasion in prostate cancer.

Authors:  Yusuke Goto; Satoko Kojima; Akira Kurozumi; Mayuko Kato; Atsushi Okato; Ryosuke Matsushita; Tomohiko Ichikawa; Naohiko Seki
Journal:  Br J Cancer       Date:  2016-04-12       Impact factor: 7.640

9.  c-Src promotes tumor progression through downregulation of microRNA-129-1-3p.

Authors:  Daisuke Okuzaki; Tomoe Yamauchi; Fumie Mitani; Mamiko Miyata; Yuichi Ninomiya; Risayo Watanabe; Hiroki Akamatsu; Chitose Oneyama
Journal:  Cancer Sci       Date:  2020-01-17       Impact factor: 6.716

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.